GOOG
75
2
CHRW
56
2
WDC
49
-4
CAH
43
2
GWW
51
-2
ECL
84
2
ADP
68
2
GIS
58
-2
SLB
46
2
BRK.B
47
2
BMY
35
2
AMGN
55
-2
HES
68
2
DLTR
44
-7
DVA
73
2
AAP
27
3
CVS
43
2
ZBH
48
-2
C
48
-2
WU
44
-2
GOOG
75
2
CHRW
56
2
WDC
49
-4
CAH
43
2
GWW
51
-2
ECL
84
2
ADP
68
2
GIS
58
-2
SLB
46
2
BRK.B
47
2
BMY
35
2
AMGN
55
-2
HES
68
2
DLTR
44
-7
DVA
73
2
AAP
27
3
CVS
43
2
ZBH
48
-2
C
48
-2
WU
44
-2
Financhill
Back

Deciphera Pharmaceuticals 10K Form

Buy
70

DCPH
Deciphera Pharmaceuticals

Last Price:
25.47
Seasonality Move:
22.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DCPH News And Ratings

See the #1 stock for the next 7 days that we like better than DCPH

DCPH Financial Statistics

Sales & Book Value

Annual Sales: $163.36M
Cash Flow: $-54.73M
Price / Cash Flow: 0
Annual Sales: $3.85
Price / Book: 6.97

Profitability

EPS (TTM): -2.21000
Net Income (TTM): $-190.42M
Gross Margin: $159.62M
Return on Equity: -50.29%
Return on Assets: -38.85%

Deciphera Pharmaceuticals Earnings Forecast

Key Deciphera Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 6 years for DCPH is 97.72%.
  • The Selling, General & Administrative Expenses for DCPH have been equal to 83.53% of Gross Profit Margin.
  • The Research & Development expenses have been 143.32% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of DCPH is -119.34% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 3 years.

Deciphera Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: DCPH
CUSIP: 24344T
Website: deciphera.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.19
Quick Ratio: 3.68

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

DCPH Technical Analysis vs Fundamental Analysis

Buy
70
Deciphera Pharmaceuticals (DCPH) is a Buy

Is Deciphera Pharmaceuticals a Buy or a Sell?